CSL Seqirus is one of the world’s largest influenza vaccine companies. We were created when our parent company, CSL Limited, acquired the Novartis influenza vaccine business and …

CSL Seqirus operates state-of-the-art manufacturing facilities on three different continents and a globally integrated supply chain for the timely supply of influenza vaccine to customers around …

Welcome to CSL Seqirus UK: We stand on the front line with partners in public health discovering, developing, and delivering pioneering seasonal and pandemic vaccine solutions to safeguard …

CSL Seqirus is a world leader in developing and producing influenza vaccines. Learn more about how we work with our partners to protect the global community.

Aug 18, 2025 · SYDNEY--Vaccine and blood-products company CSL on Tuesday unveiled a sweeping corporate restructure that will include spinning off its flu-vaccine unit Seqirus and …

CSL Seqirus Products This is a complete list of all products marketed by CSL Seqirus worldwide. Not all products are available in every country. Visit the Global Selector to link to a specific …

Aug 6, 2025 · As North Carolina continues to lead in life sciences, CSL Seqirus is proving what’s possible at the intersection of innovation, impact, and community. Through its work in Holly …

CSL Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention of seasonal influenza globally, with extensive research and advanced …

Seqirus, one of the largest influenza vaccine manufacturers in the world, is created when CSL acquires the Novartis' influenza vaccine business, combining it with bioCSL.

CSL Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention of influenza globally, with extensive research and production expertise and …